Literature DB >> 12734443

Staphylococcal resistance revisited: community-acquired methicillin resistant Staphylococcus aureus--an emerging problem for the management of skin and soft tissue infections.

E Anne Eady1, Jonathan H Cove.   

Abstract

PURPOSE OF REVIEW: In the community non-localized or deep staphylococcal skin and soft tissue infections are typically managed with beta-lactamase stable penicillins. The aims of this review are (1) to evaluate the evidence for the emergence of new strains of community-acquired methicillin resistant Staphylococcus aureus (MRSA), (2) to identify the reasons for their significant association with cutaneous infections, and (3) to consider how they arose and how big a threat they pose to the management of such infections outside hospitals. RECENT
FINDINGS: MRSA are emerging as significant community pathogens, especially in previously healthy children with no recognizable risk factors, and are predominantly associated with skin and soft tissue infections (especially abscesses and cellulitis). When present, risk factors are generally similar to those for infection with methicillin susceptible S. aureus. The MRSA isolates associated with such infections may not be entirely 'new', but could represent the displacement of some hospital clones (e.g. EMRSA-15 or variants thereof) to the community as well as the de-novo generation of novel MRSA clones by multiple horizontal transmissions of the mecA gene into methicillin susceptible S. aureus with different genetic backgrounds, some of which are already circulating globally. Community-acquired MRSA from diverse locations are non multiresistant and almost always contain the novel type IV SCCmec commonly found in coagulase-negative staphylococci, but also in hospital-associated gentamicin susceptible MRSA from France, the paediatric clone and in EMRSA-15.
SUMMARY: More local data on CA-MRSA infections are needed so that dermatologists and community physicians can assess the risk of such infections amongst their patients and avoid the inappropriate administration of beta-lactams. No simple change in prescribing practices will entirely alleviate selective pressure for the spread of community-acquired MRSA and not exacerbate resistance in pyogenic streptococci, commonly found together with S. aureus in skin and soft tissue infections. The importance of hygiene in preventing the spread of community-acquired MRSA in the community must be reemphasized.

Entities:  

Mesh:

Year:  2003        PMID: 12734443     DOI: 10.1097/00001432-200304000-00007

Source DB:  PubMed          Journal:  Curr Opin Infect Dis        ISSN: 0951-7375            Impact factor:   4.915


  85 in total

1.  Community-acquired Methicillin-resistant Staphylococcus aureus: Epidemiology and Potential Virulence Factors.

Authors:  Jose M. Eguia; Henry F. Chambers
Journal:  Curr Infect Dis Rep       Date:  2003-12       Impact factor: 3.725

2.  Widespread dissemination in The Netherlands of the epidemic berlin methicillin-resistant Staphylococcus aureus clone with low-level resistance to oxacillin.

Authors:  W J B Wannet; E Spalburg; M E O C Heck; G N Pluister; R J L Willems; A J De Neeling
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

3.  Surveillance of methicillin-resistant Staphylococcus aureus in a pediatric hospital in Mexico City during a 7-year period (1997 to 2003): clonal evolution and impact of infection control.

Authors:  M E Velazquez-Meza; M Aires de Sousa; G Echaniz-Aviles; F Solórzano-Santos; G Miranda-Novales; J Silva-Sanchez; H de Lencastre
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

4.  In vitro killing of community-associated methicillin-resistant Staphylococcus aureus with drug combinations.

Authors:  Samuel A Shelburne; Daniel M Musher; Kristina Hulten; Heather Ceasar; Michael Y Lu; Imran Bhaila; Richard J Hamill
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

5.  Commercially distributed meat as a potential vehicle for community-acquired methicillin-resistant Staphylococcus aureus.

Authors:  Kikuyo Ogata; Hiroshi Narimatsu; Masahiro Suzuki; Wataru Higuchi; Tatsuo Yamamoto; Hatsumi Taniguchi
Journal:  Appl Environ Microbiol       Date:  2012-02-03       Impact factor: 4.792

6.  Use of Oral Doxycycline for Community-acquired Methicillin-resistant Staphylococcus aureus (CA-MRSA) Infections.

Authors:  Sanjay Bhambri; Grace Kim
Journal:  J Clin Aesthet Dermatol       Date:  2009-04

7.  Identification and Discrimination of Methicillin Resistant Staphylococcus aureus Strains Isolated from Burn Wound Sites Using PCR and Authentication with MALDI-TOF-MS.

Authors:  E Madhava Charyulu; Arumugam Gnanamani; A B Mandal
Journal:  Indian J Microbiol       Date:  2012-01-14       Impact factor: 2.461

8.  Distribution of major genotypes among methicillin-resistant Staphylococcus aureus clones in Asian countries.

Authors:  Kwan Soo Ko; Ji-Young Lee; Ji Yoeun Suh; Won Sup Oh; Kyong Ran Peck; Nam Yong Lee; Jae-Hoon Song
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

9.  Emergence of virulent methicillin-resistant Staphylococcus aureus strains carrying Panton-Valentine leucocidin genes in The Netherlands.

Authors:  W J B Wannet; E Spalburg; M E O C Heck; G N Pluister; E Tiemersma; R J L Willems; X W Huijsdens; A J de Neeling; J Etienne
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

10. 

Authors:  J Solera; G Jarava
Journal:  Medicine (Madr)       Date:  2009-01-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.